Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2546597012 | Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2548896015 | Ethinyl oestradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2548897012 | Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2553789017 | Ethinyl oestradiol 0.02mg / norelgestromin 0.15mg per 24 hours transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2553790014 | Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per 24 hours transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3399371000052110 | etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Is a | Product containing ethinylestradiol and norelgestromin (medicinal product) | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Has active ingredient | Estradiol | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Has active ingredient | Norelgestromin (substance) | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Has active ingredient | Progesterone | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Has manufactured dose form | kutan och/eller transdermal läkemedelsform | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Is a | icke-peroralt preventivmedel | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Is a | läkemedelsform för lokalt bruk | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Has manufactured dose form | Prolonged-release transdermal patch (dose form) | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Is a | Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | false | Inferred relationship | Some | ||
| etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR